Cambridge Cognition Holdings logo

COG - Cambridge Cognition Holdings Share Price

144.5p -3.5  -2.4%

Last Trade - 17/06/21

Micro Cap
Market Cap ÂŁ46.1m
Enterprise Value ÂŁ43.2m
Revenue ÂŁ6.74m
Position in Universe 1286th / 1812
Unlock COG Revenue
Relative Strength (%)
1m +17.1%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.27%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
5.04 6.88 6.73 6.13 5.04 6.74 8.50 +6.0%
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020,Cambridge Cognition Holdings PLC revenues increased 34% toÂŁ6.7M. Net loss decreased 85% to ÂŁ438K. Revenues reflectServices segment increase of 57% to ÂŁ3.7M, Software segmentincrease of 9% to ÂŁ2.8M, United States of America segmentincrease of 83% to ÂŁ4.6M, Rest of World segment increase of6% to ÂŁ726K. Lower net loss reflects Administrativeexpenses decrease of 13% to ÂŁ6.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for COG
Graphical History


COG Revenue Unlock COG Revenue

Net Income

COG Net Income Unlock COG Revenue

Normalised EPS

COG Normalised EPS Unlock COG Revenue

PE Ratio Range

COG PE Ratio Range Unlock COG Revenue

Dividend Yield Range

COG Dividend Yield Range Unlock COG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
COG EPS Forecasts Unlock COG Revenue
Profile Summary

Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company's segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials. The Academic Research segment includes cognitive test products for researchers working in a non-regulated environment, typically in academia. The Healthcare Technology segment includes medical software for use in healthcare delivery settings. The Company is a provider of validated touchscreen cognitive assessments for clinical trials. The Company's product, CANTAB Mobile is a Class II medical device, used to identify patients exhibiting the early signs of Alzheimer's disease. It also offers Cantab Insight for dementia assessment in secondary care.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated September 12, 2012
Public Since April 18, 2013
No. of Shareholders: n/a
No. of Employees: 58
Sector Technology
Industry Software & IT Services
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 31,170,093
Free Float (0.0%)
Eligible for
COG Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for COG
Upcoming Events for COG
Frequently Asked Questions for Cambridge Cognition Holdings
What is the Cambridge Cognition Holdings share price?

As of 17/06/21, shares in Cambridge Cognition Holdings are trading at 144.5p, giving the company a market capitalisation of ÂŁ46.1m. This share price information is delayed by 15 minutes.

How has the Cambridge Cognition Holdings share price performed this year?

Shares in Cambridge Cognition Holdings are currently trading at 144.5p and the price has moved by 0.438k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cambridge Cognition Holdings price has moved by 0.357k% over the past year.

What are the analyst and broker recommendations for Cambridge Cognition Holdings?

Of the analysts with advisory recommendations for Cambridge Cognition Holdings, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cambridge Cognition Holdings is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cambridge Cognition Holdings next release its financial results?

Cambridge Cognition Holdings is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Cambridge Cognition Holdings dividend yield?

Cambridge Cognition Holdings does not currently pay a dividend.

Does Cambridge Cognition Holdings pay a dividend?

Cambridge Cognition Holdings does not currently pay a dividend.

When does Cambridge Cognition Holdings next pay dividends?

Cambridge Cognition Holdings does not currently pay a dividend.

How do I buy Cambridge Cognition Holdings shares?

To buy shares in Cambridge Cognition Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cambridge Cognition Holdings?

Shares in Cambridge Cognition Holdings are currently trading at 144.5p, giving the company a market capitalisation of ÂŁ46.1m.

Where are Cambridge Cognition Holdings shares listed? Where are Cambridge Cognition Holdings shares listed?

Here are the trading details for Cambridge Cognition Holdings:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: COG
What kind of share is Cambridge Cognition Holdings?

Based on an overall assessment of its quality, value and momentum, Cambridge Cognition Holdings is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cambridge Cognition Holdings share price forecast 2021?

Shares in Cambridge Cognition Holdings are currently priced at 144.5p. At that level they are trading at 15.54% premium to the analyst consensus target price of 125.06.

Analysts covering Cambridge Cognition Holdings currently have a consensus Earnings Per Share (EPS) forecast of 0.007 for the next financial year.

How can I tell whether the Cambridge Cognition Holdings share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cambridge Cognition Holdings. Over the past six months, the relative strength of its shares against the market has been 0.141k%. At the current price of 144.5p, shares in Cambridge Cognition Holdings are trading at 86.84% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cambridge Cognition Holdings PE Ratio?

We were not able to find PE ratio data for Cambridge Cognition Holdings.

Who are the key directors of Cambridge Cognition Holdings?

Cambridge Cognition Holdings's management team is headed by:

Andrew Blackwell - NED
Steven Powell - NEC
Matthew Stork - CEO
Debra Leeves - NED
Richard Bungay - NED
Michael Holton - CFO
Who are the major shareholders of Cambridge Cognition Holdings?

Here are the top five shareholders of Cambridge Cognition Holdings based on the size of their shareholding:

Wray (Nigel William) Individual Investor
Percentage owned: 15.56% (4.85m shares)
Canaccord Genuity Wealth Management Investment Advisor/Hedge Fund
Percentage owned: 10% (3.12m shares)
Buxton (Michael) Individual Investor
Percentage owned: 7% (2.18m shares)
Marlborough UK Micro Cap Growth Retail Mutual Fund
Percentage owned: 6.42% (2.00m shares)
Gordon (Brett) Individual Investor
Percentage owned: 6.05% (1.89m shares)
Similar to COG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.